Secondary Myelofibrosis

general

Myelofibrosis that develops in patients with a history of hematologic malignancies or toxic injury to the bone marrow.

18

Centers

10

Active Trials

Cancer Funding

Top Centers for Secondary Myelofibrosis(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
62.8
2
NCI Comprehensive
Active Research Program
62.8
362.8
4
NCI Comprehensive
Active Research Program
62.8
5
NCI Comprehensive
Active Research Program
62.8
6
NCI Clinical
Active Research Program
62.8
7
NCI Comprehensive
Active Research Program
62.8
8
NCI Comprehensive
Active Research Program
62.8
9
Active Research Program
62.8
10
Active Research Program
62.8
11
NCI Comprehensive
40.3
12
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
40.3
13
NCI Comprehensive
40.3
14
NCI Comprehensive
40.3
1540.3
16
NCI Comprehensive
40.3
17
BC CancerVancouver, BC
40.3
1840.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →